Abstract Objective-To compare the effects of sodium depletion and of angiotensin I converting enzyme inhibition on microalbuminuria in insulin dependent diabetes.
Design-Randomised, double blind, double dummy parallel study of normotensive diabetic patients with persistent microalbuminuria (30-300 mg/24 h) treated with enalapril or hydrochlorothiazide for one year after a three month, single blind placebo period.
Setting-Diabetic clinic in a tertiary referral centre.
Patients-10 diabetic patients with low microalbuminuria mg/24 h) and 11 with high microalbuminuria (100-300 mg/24 h).
Interventions-1I subjects (six with low microalbuminuria, five with high microalbuminuria) were given enalapril 20 mg plus placebo hydrochlorothiazide once daily and 10 (four with low microalbuminuria, six with high microalbuminuria) hydrochlorothiazide 25 mg plus placebo enalapril once daily.
Main outcome measures-Monthly assessment of urinary albumin excretion and mean arterial pressure; plasma active renin and aldosterone concentrations and renal function studies at 0, 6, and 12 months.
Results-Median urinary albumin excretion decreased from 59 (range 37-260) to 38 mg/24 h with enalapril and from 111 The decrease in microalbuminuria observed with angiotensin I converting enzyme inhibitors in normotensive diabetic patients8 * could be the result of inhibition of the renin-angiotensin system's effects on blood pressure or its effect on intraglomerular haemodynamics, or both. It is important to delineate these drugs' mechanisms of action in decreasing urinary albumin excretion in diabetic patients because classic antihypertensive drugs reduce both the rate of progression of diabetic nephropathy" and microalbuminuria in normotensive diabetic patients in the short term." Therefore, intervention with hypotensive drugs other than angiotensin converting enzyme inhibitors should be considered. In a recent report no difference was found between the effects of perindopril and nifedipine on patients' microalbuminuria and blood pressure over one year. 2 To discover whether blockade of the renin-angiotensin system by angiotensin I converting enzyme inhibitors contributes to reducing microalbuminuria in normotensive diabetic patients independently of the fall in blood pressure, we compared enalapril's effects on urinary albumin excretion with those of another antihypertensive drug, hydrochlorothiazide, which, unlike enalapril, decreases blood pressure by sodium depletion while stimulating the renin-angiotensin system.'3 Hydrochlorothiazide is a longstanding antihypertensive drug used as first line treatment in essential hypertension and has also been used safely in normotensive subjects with idiopathic hypercalciuria.'4 Subclinical sodium retention may be an important feature in insulin treated patients who have diabetic glomerulopathy, even if the renin-angiotensin system activity seems to be normal in such patients."' If sodium retention has an important role in the development of diabetic renal disease a diuretic drug should reduce blood pressure and protect renal function. The primary objective of our study was to compare the changes in microalbuminuria resulting from long term sodium depletion induced by hydrochlorothiazide with those resulting from inhibition of the reninangiotensin system.
Patients and methods

PATIENTS
Patients were selected from a group of 496 patients with insulin dependent diabetes who attended our clinic regularly, according to the following criteria: they were aged 18-60, had insulin dependent diabetes mellitus of at least five years' duration, had a stable body mass index not exceeding 30 kg/M2, a glycated haemoglobin concentration of less than 10%, were not hypertensive (supine blood pressure less than 160/95 mm Hg and no antihypertensive treatment), had persistent microalbuminuria-that is, urinary albumin excretion between 30 and 300 mg/24 h at least twice during the previous six months'5-were not pregnant or wanting to be pregnant, and had no chronic disease other than diabetes. Thirty four patients fulfilled these criteria; of these, 25 thiazide group). Tablets were taken every morning. The doses of 20 mg enalapril and 25 mg hydrochlorothiazide were chosen because they had a similar hypotensive effect in a previous short term pilot study we conducted in diabetic patients with similar characteristics. ' The patients were instructed to follow a constant isocaloric diet (mean 9098 (SD 1574) J/day) composed of 50% carbohydrate, 35% lipid, and 15% protein without any restriction of sodium intake. The same investigator (MH) managed all patients throughout the study.
MEASUREMENTS
Urinary albumin excretion was measured monthly in 24 hour urine samples by nephelometry'8 (sensitivity of the assay 0-2 mg/l; intra-assay and interassay variability 4% and 5% respectively). Variability in 24 hour urinary albumin excretion within and between subjects was 35% and 66% respectively. After log transformation of urinary albumin excretion the variabilities were 8% and 14% respectively. We classified each participant as having persistently normal urinary albumin excretion, persistently low microalbuminuria, high microalbuminuria, or macroalbuminuria if at least two of three successive measurements were, respectively, below 30 mg/24 h, between 30 and 99 mg/24 h, between 100 and 300 mg/24 h, or above 300 mg/24 h. 696 The systolic, diastolic, and mean arterial pressures were recorded as described previously'9 with an automatic device (Dinamap, Critikon, Florida; cuff size 23-13 cm/13 cm) every three minutes for 30 minutes between 0900 and 1100 while the patient was supine, and the mean of these 10 values was recorded. The variability in mean arterial pressure within and between subjects was 4% and 6% respectively. The mean arterial pressure recorded with this device correlated highly with values calculated from mean blood pressure obtained with a mercury sphygmomanometer in the same conditions (r=0-72; p < 0-000 1).
On the day of the renal function study blood samples were taken from fasted patients who had spent the night supine; serum converting enzyme activity and plasma concentrations oftotal and active renin and aldosterone were determined. The placebo (time= 0) or active treatment (time=6 and 12 months) tablets were then taken after these samplings. Patients were not given their moming insulin. A diuresis of 10-15 ml/min was induced by progressive water loading, and glomerular filtration rate and effective renal plasma flow were derived, respectively, from the mean clearances of iodothalamate labelled with iodine-125 and hippurate labelled with iodine-131 over six successive 20 minute periods,3 as published previously'9 (median variabilities within subjects and between periods 9% and 12% respectively). 
, urinary albumin and sodium excretion and mean arterial pressure-obtained from all included subjects during the last three months of their follow up were carried forward. The second was an analysis of treatment given to the 21 subjects who completed the study.
Results
Thirteen patients were included in the enalapril group and 12 in the hydrochlorothiazide group. Tables  I and II show their clinical characteristics. The two groups were strictly similar for all variables, especially for initial blood pressure and urinary albumin excretion. Two patients from each group were excluded from the study after six months of active treatment. In the enalapril group two patients (cases 9 and 10) (both initially with low microalbuminuria) decided to withdraw from the trial because they wished to become pregnant (at withdrawal both displayed persistent normoalbuminuria, which persisted after stopping experimental treatment). In the hydrochlorothiazide group one patient (case 20) (initially with high microalbuminuria) developed high blood pressure not controlled after six months of treatment (he still had high microalbuminuria at this time), and he was therefore excluded according to the protocol. Another (case 21 (x2=l19; p>0 3). During the last three months of treatment five patients taking enalapril displayed a persistent normoalbuminuria, five a low microalbuminuria, and one a high microalbuminuria, whereas in the hydrochlorothiazide group one patient had persistent normoalbuminuria, three low microalbuminuria, and six high microalbuminuria (X2=6-7; p=0 03). With enalapril urinary albumin excretion declined from 59 (37-260) mg/24 h during placebo to 38 (14-146) mg/24 h during the last three months of study, while it varied from 111 (33-282) to 109 (33-262) mg/ 24 h with hydrochlorothiazide. Thus, the median difference in urinary albumin excretion reduction was -57 mg/24 h (95% confidence interval 15 to 114) in favour of enalapril. Urinary albumin excretion was reduced by 20% (-50 to 10) with enalapril at the end of follow up v 2% (-36 to 32) with hydrochlorothiazide (p=0-0176).
Mean arterial pressure was not different between the two groups during the placebo period 98 (7) mm Hg in enalapril group v 97 (9) mm Hg in hydrochlorothiazide group; p=0 9004) or during the whole treatment decreased by enalapril but increased by hydrochlorothiazide (table IV) . Plasma uric acid concentration rose with hydrochlorothiazide but not enalapril (table IV) . Plasma concentrations of electrolytes and creatinine, lipid variables, and daily insulin doses remained steady throughout the study (not shown).
No clinical side effect was observed throughout the study.
Discussion
Effective renin-angiotensin system blockade with enalapril, shown by the fall in serum angiotensin I converting enzyme activity and the rise in plasma active renin concentration without changes in plasma aldosterone concentration, significantly reduced the microalbuminuria of normotensive diabetic patients within one year of treatment. Conversely, the sodium depletion induced by a low dose of hydrochlorothiazide, shown by the rise in plasma uric acid, active renin, and aldosterone concentrations, did not reduce microalbuminuria after one year's treatment.
Our study design explains how we could detect a significant difference in urinary albumin excretion between two treatments in a small number of subjects for a short period of time: monthly measurements over 12 months increased the precision and consequently Confounding variables which may have affected urinary albumin excretion were similar within and between our two groups-that is, glycaemic control, weight, and protein intake (as reflected by urinary urea excretion). Mean arterial pressure was the most important variable to adjust for between the two groups. During this trial, five of the 11 patients taking enalapril were normoalbuminuric after one year of treatment, while mean arterial pressure decreased by 10 Finally, different antihypertensive drugs' appropriateness for the impaired renal function of diabetic subjects should be determined by their differences concerning clinically relevant end points-for example, difference in the rate of deterioration in the glomerular filtration rate. We showed that enalapril prevented such deterioration in normotensive diabetics with microalbuminuria compared with placebo." Here, no difference was observed between enalapril and hydrochlorothiazide on the glomerular filtration rate; however this study's design (conceptualised exclusively for studying microalbuminuria) does not allow such a difference to be ruled out. In previous long term trials with glycaemic control intervention the change in microalbuminuria was an accurate reflection of the change in glomerular filtration rate.56 If microalbuminuria is an appropriate surrogate end point that could replace glomerular filtration rate changes in clinical trials, one can anticipate that enalapril will protect glomerular filtration rate better than hydrochlorothiazide in the long term. In this connection Bjork et al reported that enalapril protected glomerular filtration rate more effectively than metoprolol in diabetic nephropathy after four years of follow Up. 37 Normotensive diabetic subjects with microalbuminuria may exhibit a reduced glomerular filtration rate and hypertension secondary to glomerular disease very rapidly in the absence of intervention.689 Therefore, it is timely to compare angiotensin I converting enzyme inhibitors with other antihypertensive drugs on glomerular filtration rate in a representative sample of normotensive patients with insulin dependent diabetes and persistent microalbuminuria.
Introduction
Endometriosis is a condition in which there is functioning endometrial tissue outside the uterine cavity.' The disease process is usually limited to the pelvis and clinical manifestations include pain, menstrual disorders, infertility, and pelvic masses. Diagnosis by clinical methods is unreliable and confirmation is required by laparoscopy or laparotomy.
In view of the lack of epidemiological information about endometriosis, we decided to analyse the available data in the Oxford Family Planning Association contraceptive study.
Subjects and methods
The methods used in the Oxford Family Planning Association study have been described in detail elsewhere.' In brief, 17032 women were recruited at 17 large family planning clinics in England and Scotland during 1968-74. To be eligible for the study women had to be white, British, married, aged 25-39 years, and to have been taking oral contraceptives for at least five months, or using a diaphragm or intrauterine device for at least five months without previous exposure to oral contraceptives. About 99% of those approached consented to participate in the study and follow up is still continuing.
At return visits to the clinic women are questioned by a doctor or a nurse and the information recorded on a special form, including details of pregnancies and their outcome, changes in contraceptive practices, and reasons for referral to hospital. Women who stop attending the clinic are sent a postal version of the questionnaire and, if this is not returned, are interviewed over the telephone or at a home visit. Each hospital admission is followed up by writing to the consultant concerned to obtain a copy of the discharge summary. The work in each clinic is coordinated by a part time research assistant, and follow up has been maintained with an annual loss because of withdrawal of cooperation or loss of contact of only about 03%. Only women who have never taken the pill and those who have taken it for eight or more years are followed up beyond the age of 45.
The study collects detailed morbidity information only about illnesses requiring referral to hospital. This was not a limitation in this analysis because endometriosis has to be diagnosed by laparoscopy or laparotomy. The numbers of cases per 1000 woman years of observation in the various groups were compared. Rates of first diagnosis for endometriosis within these groups were standardised by the indirect method.)
